Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Clues For Brain Cancer Treatment Found At The ESRF

05.04.2004


A team of researchers from the University Hospital of Grenoble (CHU – Inserm U647) and the ESRF1 has found a new treatment that improves the survival of rats with high-grade gliomas.



This research was carried out at the ESRF Medical Beamline. It showed that after a year of this treatment, three rats out of 10 were considered cured, whereas without treatment, all would be dead. The results have just been published in the scientific journal Cancer Research. A glioma is one of the most frequent brain tumours in human adults, and it is not curable. Clinical trials on humans are planned for the near future.

Today, the median survival for patients with glioma is less than a year. Around 5 to 10 adults out of 100.000 suffer from this brain tumour. Traditional radiotherapy using hospital X-rays only has a palliative effect because gliomas are some of the most radio-resistant human tumours. Chemotherapy is ineffective most of the time. Several therapeutic techniques have been developed over the last years using animal models, but none has had such successful results as this new treatment with cis-platinum combined with monochromatic synchrotron x-rays. This new technique combines chemotherapy with radiotherapy in such a way that both techniques are effective when associated.


In this study, a drug called Cis-platinum was injected into the brain of rats bearing F98 glioma. The substance entered the DNAs of the tumour and limited the tumoral proliferation. A day later, at the Medical Beamline of the ESRF, the tumour was irradiated with X-rays of a very precise energy (monochromatic) The difference between these X-rays and the conventional X-ray sources used in hospitals is the brilliance: the beam produced by the ESRF synchrotron is a hundred thousand times brighter than the beam produced by a hospital X-ray machine, allowing the beam to be tuned at a convenient wavelength.

This in vivo experiment was preceded by in vitro experiments on cells using the same tumoral model (F98). This tumour is extremely radioresistant and it spreads very quickly. The mean survival time of untreated rats was 28 days. If cis-platinum was injected, they survived up to 39 days. If the rats were irradiated with X-rays at a certain wavelength, it could result in a maximum of 48 days of survival. The combination of both treatments, with a specific radiation dose and a specific X-ray wavelength appeared to be the most efficient treatment tested and offered a mean survival time of around 200 days. This means a 6-fold increase in the life span of treated rats compared to those which didn’t receive any treatment.

The success of the trials has led CHU and ESRF researchers to envisage the elaboration of a protocol in order to use these techniques on humans. “There is a lot of technological development to be carried out, but it is feasible”, explains Doctor François Estève, one of the authors of the paper. “The ESRF Medical Beamline is a unique place in the world where pre-clinical and clinical research in radiotherapy with synchrotron radiation is possible nowadays” says Doctor Alberto Bravin, responsible for the Medical Beamline. Rats and humans don’t have so much physical resemblance, so doctors and physicists still cannot say whether they would have the same outstanding results if humans were treated. But François Estève is convinced that “taking into account the impossibility nowadays of healing this brain tumour, it is really a must to try this method”.

Montserrat Capellas | alfa
Further information:
http://www.esrf.fr

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
18.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>